Maelstrom Research Staging | PWH_COVID19_Control_Additional

PWH_COVID19_Control_Additional_visit8b

Networks -

Variables -

Associated study PWH-COVID19 Contingency Table

Population

PWH-COVID19 - Control

The population is composed of HIV negative individuals matched for age and sex with PWH individuals.

Selection Criteria

Minimum age

Newborns

Twins

Countries

Canada

Territory

Ethnic Origin

Health Status

Inclusion criteria: * Negative HIV test at the screening visit. * Stable clinical status and absence of acute illnesses as shown by medical history and screening laboratory tests at the screening visit: Hemoglobin ≥ 85 g/L White blood cell (WBC) count = 3300 to 12,000 cells/mm3; Total lymphocyte count ≥ 800 cells/mm3; Platelets = 50,000 to 550,000/mm3; Chemistry panel: alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase < 5 times the institutional upper limit of normal (ULN); creatinine (Cr) ≤ institutional upper limit of normal; creatine phosphokinase (CPK) ≤ 2 times the institutional upper limit of normal not related to physical exertion.

Other Criteria

Exclusion criteria: * Participant with other significant underlying disease (non-HIV-1) that might impinge upon disease progression or death. * Further, pariticipants with immune-compromising conditions or on medication which suppresses the immune response will not be included in the study.

Recruitment

Sources of recruitment

General population

General Population

Volunteer enrolment

Number of Participants

Number of Participants: 23
Number of Participants with Biological Samples: 23

More info

Data Collection Event

PWH-COVID19 - Control - Additional visit 8b

Information about vaccination (vaccination card) is collected. Documentation of COVID-19 infection is assessed by specific symptoms and at least one nasopharyngeal swab, nasal swab, or saliva sample (or respiratory sample if the participant was hospitalized) that is positive for SARS-CoV-2 by reverse-transcriptase-polymerase-chain-reaction (RT-PCR) test. Immediate vaccine reactogenicity is assessed. Saliva and blood are also collected.

More info

Collected Dataset / PWH_COVID19_Control_Additional_visit8b

PWH_COVID19_Control_Additional_visit8b

Population

PWH-COVID19 - Control

Data Collection Event

PWH-COVID19 - Control - Additional visit 8b

Files

Variables Classifications